Navigation Links
Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
Date:1/13/2009

BOSTON, Jan. 13 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment bank, is pleased to announce that Michael D. Webb has joined the firm as senior advisor. In this role, Mr. Webb will participate with the firm on internal and client-related activities including merger & acquisition advisory services and private equity placements, with a particular focus on biopharmaceutical transactions. "We are delighted to have someone of Mike's caliber join the Johnston Blakely team," said Johnston Blakely founder Benjamin Conway. "His extensive senior management experience and depth of sector knowledge will be of tremendous value to both the firm and its clients."

Mr. Webb was previously President & CEO of EPIX Pharmaceuticals where he completed over $225 million in financings, including its 1997 IPO, and raised an additional $150 million through corporate partnerships. Prior to EPIX, Mr. Webb was Senior Vice President, Worldwide Marketing and Strategic Planning for Ciba Diagnostics. Most recently he has been active with Ascent Therapeutics where as founder, president & CEO he organized the company and secured its initial $20 million in venture financing. Mr. Webb holds an M.B.A. with highest honors from Northwestern University's Kellogg Graduate School of Management.

About Johnston Blakely & Company

Johnston Blakely & Company, LLC is a Boston-based investment bank offering merger & acquisition-related financial advisory and private equity placement services to companies in the life science sector. The firm incorporates the venture capital tradition of comprehensive company involvement into investment banking engagements to deliver superior results for its clients. More than investment banking...inVenture banking(TM).

Johnston Blakely is a registered broker/dealer and member of FINRA/SIPC.


'/>"/>
SOURCE Johnston Blakely & Company, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
2. Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product
3. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
4. Micromet Added to NASDAQ Biotechnology Index
5. Far From Beyond: A Glimpse into the World of Biotechnology and the Future of the Free World
6. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
7. Yongye Biotechnology Announces Record Third Quarter Results
8. World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
11. InNexus Biotechnology Receives Patent Grants in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... will hold its 2015 Annual Meeting of Stockholders on ... the expected date for the Annual Meeting represents a ...
(Date:12/24/2014)... MD (PRWEB) December 23, 2014 ... into law H.R. 83, the Omnibus and Continuing ... first time, made hydrocephalus a condition eligible to ... Programs (CDMRP) administered by the Department of Defense ... with its allies on Capitol Hill, is celebrating ...
(Date:12/24/2014)... Pipette.com announces their Holiday in the ... their #HolidayInTheLab pictures for a chance to win pipette-themed ... those struggling to think of a holiday gift for ... Lab Contest provides the ideal holiday presents. The #HolidayInTheLab ... pictures of their chemistree, holiday sweaters, as well as ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... , , WALTHAM, Mass., Aug. ... and advisory firms focusing on pharmaceutical and healthcare issues, finds ... in second- and third-line therapy since last year,s analysis of ... to the publication of the ENHANCE trial which called into ...
... , , SUNNYVALE, Calif., ... ), a global leader in the field of radiosurgery, today announced ... has purchased a CyberKnife(R) Robotic Radiosurgery System. This marks the seventh ... RoboCouch Patient Positioning System. GNUH is the first national university hospital ...
... China, Aug. 12 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. (OTC ... developer, manufacturer and supplier of pharmaceutical,products and medical ... announced that management will hold a conference call ... EDT on Friday, August 14, 2009. Financial,results ...
Cached Biology Technology:Merck/Schering-Plough's Zetia and Vytorin Have Lost Substantial Patient Share in Second- and Third-Line Therapy Since Last Year's Analysis of Dyslipidemia 2Merck/Schering-Plough's Zetia and Vytorin Have Lost Substantial Patient Share in Second- and Third-Line Therapy Since Last Year's Analysis of Dyslipidemia 3Seventh CyberKnife System in South Korea Purchased 2Seventh CyberKnife System in South Korea Purchased 3Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT 2Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT 3
(Date:12/17/2014)... 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... technology than the iPhone 5S, Samsung introduces for ... product. The Galaxy S5 home button ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally ... more evident than at international borders. Over the ... scanners have allowed veteran travelers to self process ... Control (APC) Kiosks at an increasing number of ... According to Maxine Most ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... sources, researchers are looking more to plants that grow in ... However, attempts to "domesticate" wild-growing plants have a downside, ... number of plant viruses. In a presentation at this ... Science, Michigan State University plant biologist Carolyn Malmstrom said that ...
... can break down plant biomass into the precursors of biodiesel ... produce alternatives to petroleum. But the potential of this "biorefinery" ... break down lignin, a highly stable polymer that makes up ... Streptomyces bacteria are among few microorganisms known to degrade ...
... The protein structure of the motor that propels archaea ... team of scientists from the U.S. Department of Energy,s ... Planck Institute (MPI) for Terrestrial Microbiology. The ... long been called a flagellum, a whip-like filament that, ...
Cached Biology News:Avoiding virus dangers in 'domesticating' wild plants for biofuel use 2A microbial biorefinery provides new insight into how bacteria regulate genes 2A microbial biorefinery provides new insight into how bacteria regulate genes 3Revealing the secrets of motility in archaea 2Revealing the secrets of motility in archaea 3Revealing the secrets of motility in archaea 4Revealing the secrets of motility in archaea 5
MagSi monodispers, magnetic silica particles with modified surface for SO3 coupling chemistry....
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... repeat and SOCS box-containing protein) This polyclonal ... amino acids 75-93 and 348-368 of human ... No. 40149) can be used as a ... mouse and rat Asb-2, based on amino ...
Biology Products: